Kuur Therapeutics

📍 Houston, United States👥 8 employees💰 Last funded Mar 2020
Biotechnology Research🌐 kuurtx.com
Website LinkedIn
Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Kuur Therapeutics?
Kuur Therapeutics has 1 investors on record on gritt.io.
When did Kuur Therapeutics last raise funding?
The most recent investment in Kuur Therapeutics recorded on gritt.io was in March 2020.
What industry is Kuur Therapeutics in?
Kuur Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kuur Therapeutics based?
Kuur Therapeutics is headquartered in Houston, United States.